Cue Biopharma (1UC.F) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.26
-0.25
-0.24
-0.23

Details

Expected EPS
-0.2614704
Actual EPS
-0.2318
Surprise EPS
0.03
Surprise Percent
+11.35%

Description

Cue Biopharma (1UC.F) has reported earnings of -0.2318 per share for Q2 2024.

0 Comments

Share your thoughts